These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 34387835)

  • 1. Lower Serum Angiotensin-Converting Enzyme Level in Relation to Hyperinflammation and Impaired Antiviral Immune Response Contributes to Progression of COVID-19 Infection.
    Chen Y; Huang D; Yuan W; Chang J; Yuan Z; Wu D; Han M; Luo X; Ning Q; Yan W
    Infect Dis Ther; 2021 Dec; 10(4):2431-2446. PubMed ID: 34387835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension: A Single-Center Retrospective Study.
    Yang G; Tan Z; Zhou L; Yang M; Peng L; Liu J; Cai J; Yang R; Han J; Huang Y; He S
    Hypertension; 2020 Jul; 76(1):51-58. PubMed ID: 32348166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme as a new immunologic target for the new SARS-CoV-2.
    Hallaj S; Ghorbani A; Mousavi-Aghdas SA; Mirza-Aghazadeh-Attari M; Sevbitov A; Hashemi V; Hallaj T; Jadidi-Niaragh F
    Immunol Cell Biol; 2021 Feb; 99(2):192-205. PubMed ID: 32864784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus].
    Verdecchia P; Reboldi G; Cavallini C; Mazzotta G; Angeli F
    G Ital Cardiol (Rome); 2020 May; 21(5):321-327. PubMed ID: 32310915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The assessment of serum ACE activity in COVID-19 and its association with clinical features and severity of the disease.
    Avanoglu Guler A; Tombul N; Aysert Yıldız P; Özger HS; Hızel K; Gulbahar O; Tufan A; Erbaş G; Aygencel G; Guzel Tunçcan O; Dizbay M; Öztürk MA
    Scand J Clin Lab Invest; 2021 Apr; 81(2):160-165. PubMed ID: 33474994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of ACE (I/D) and ACE2 receptor gene (Rs2106809, Rs2285666) are not related to the clinical course of COVID-19: A case study.
    Karakaş Çelik S; Çakmak Genç G; Pişkin N; Açikgöz B; Altinsoy B; Kurucu İşsiz B; Dursun A
    J Med Virol; 2021 Oct; 93(10):5947-5952. PubMed ID: 34170561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients With Coronavirus Disease 2019: Friend or Foe?
    Shyh GI; Nawarskas JJ; Cheng-Lai A
    Cardiol Rev; 2020; 28(4):213-216. PubMed ID: 32496364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With the Risk of Hospitalization and Death in Hypertensive Patients With COVID-19.
    Khera R; Clark C; Lu Y; Guo Y; Ren S; Truax B; Spatz ES; Murugiah K; Lin Z; Omer SB; Vojta D; Krumholz HM
    J Am Heart Assoc; 2021 Jul; 10(13):e018086. PubMed ID: 33624516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAAS Blockade and COVID-19: Mechanistic Modeling of Mas and AT1 Receptor Occupancy as Indicators of Pro-Inflammatory and Anti-Inflammatory Balance.
    Melissa Hallow K; Dave I
    Clin Pharmacol Ther; 2021 Apr; 109(4):1092-1103. PubMed ID: 33506503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the Backbenchers of the Renin-Angiotensin System ACE2 and AT2 Receptors in COVID-19: Lessons From SARS.
    Gumashta J; Gumashta R
    Cureus; 2020 Jun; 12(6):e8411. PubMed ID: 32626626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection.
    Verdecchia P; Cavallini C; Spanevello A; Angeli F
    Eur J Intern Med; 2020 Jun; 76():14-20. PubMed ID: 32336612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and characterization of ACE2 - a 20-year journey of surprises from vasopeptidase to COVID-19.
    Hooper NM; Lambert DW; Turner AJ
    Clin Sci (Lond); 2020 Sep; 134(18):2489-2501. PubMed ID: 32990314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors.
    Sama IE; Ravera A; Santema BT; van Goor H; Ter Maaten JM; Cleland JGF; Rienstra M; Friedrich AW; Samani NJ; Ng LL; Dickstein K; Lang CC; Filippatos G; Anker SD; Ponikowski P; Metra M; van Veldhuisen DJ; Voors AA
    Eur Heart J; 2020 May; 41(19):1810-1817. PubMed ID: 32388565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum ACE activity and plasma ACE concentration in patients with SARS-CoV-2 infection.
    Henry BM; Benoit JL; Rose J; de Oliveira MHS; Lippi G; Benoit SW
    Scand J Clin Lab Invest; 2021 Jul; 81(4):272-275. PubMed ID: 34003706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Angiotensin Converting Enzyme Deletion/Deletion Genotype Is a Risk Factor for Severe COVID-19: Implication and Utility for Patients Admitted to Emergency Department.
    Annunziata A; Coppola A; Di Spirito V; Cauteruccio R; Marotta A; Micco PD; Fiorentino G
    Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441050
    [No Abstract]   [Full Text] [Related]  

  • 16. Association of ACE inhibitors and angiotensin type II blockers with ACE2 overexpression in COVID-19 comorbidities: A pathway-based analytical study.
    Parit R; Jayavel S
    Eur J Pharmacol; 2021 Apr; 896():173899. PubMed ID: 33508281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular Pathology and Occasionally Detectable Intraocular Severe Acute Respiratory Syndrome Coronavirus-2 RNA in Five Fatal Coronavirus Disease-19 Cases.
    Reinhold A; Tzankov A; Matter MS; Mihic-Probst D; Scholl HPN; Meyer P
    Ophthalmic Res; 2021; 64(5):785-792. PubMed ID: 33472206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance between COVID-19 and host genetics of immune response.
    Taher I; Almaeen A; Ghazy A; Abu-Farha M; Mohamed Channanath A; Elsa John S; Hebbar P; Arefanian H; Abubaker J; Al-Mulla F; Alphonse Thanaraj T
    Saudi J Biol Sci; 2021 Nov; 28(11):6645-6652. PubMed ID: 34305429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19.
    Şenkal N; Meral R; Medetalibeyoğlu A; Konyaoğlu H; Kose M; Tukek T
    Anatol J Cardiol; 2020 Jul; 24(1):21-29. PubMed ID: 32628137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JAK Inhibition as a New Treatment Strategy for Patients with COVID-19.
    Seif F; Aazami H; Khoshmirsafa M; Kamali M; Mohsenzadegan M; Pornour M; Mansouri D
    Int Arch Allergy Immunol; 2020; 181(6):467-475. PubMed ID: 32392562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.